Data story · ASPS 2005–2024
The Secret Weapon
of Cosmetic Surgery
Nobody writes thinkpieces about liposuction. And yet it's the #1 cosmetic surgical procedure in America — more than breast augmentation, more than tummy tucks, more than anything else. It just needs a better publicist.
#1
Surgical procedure
since 2020
+73%
Growth from
2012 trough
6%
Male patients
(21K in 2024)
Liposuction started as the volume leader in 2005 (324K), lost the #1 spot to augmentation in 2007–2019, then reclaimed the crown in 2020. By 2024, it leads augmentation by 43,532 procedures. From the 2012 trough of 202K to 2024's 350K, liposuction grew 73%.
Liposuction Breast Augmentation Tummy Tuck Breast Lift
COVID was the turning point. Both liposuction and augmentation crashed in 2020, but lipo recovered faster and surged higher. By 2022, it retook #1 for good.
Unlike tummy tucks (96% female) and breast procedures (97%+ female), liposuction has a meaningful male patient population. Male liposuction has been a consistent 20K–36K procedures per year, though the male share dropped from 11% to 6% as female volumes surged post-COVID.
Liposuction has a broader age distribution than most procedures. The 40–54 group accounts for 45% (2024), the 30–39 group adds 26%, the 20–29 group holds at 8%. This reflects liposuction's versatility — it treats localized fat deposits that affect people of all ages.
The 40–54 bracket is pulling away. Its share grew from 39–40% (2006–2018) to 45% (2024). The 30–39 share dropped from 33% to 26%. The demographic is aging — but the volume keeps growing.
The South Atlantic region (driven by Florida) surged to 35% of all liposuction in 2023, overtaking the Pacific region (24%). The geographic shift reflects Florida's rise as a cosmetic surgery destination and California's declining dominance.
Liposuction didn't just recover from COVID. It grew 32% beyond its 2019 level. That 84,500-procedure increase is enormous — equivalent to adding the entire annual volume of a medium-sized surgical specialty. Remote work recovery, GLP-1 drugs, and social media normalization all contributed.
2019 (pre-pandemic)
265,209
The GLP-1 tailwind is uniquely strong for liposuction. Weight-loss drugs reduce fat unevenly — patients lose from the face and breasts but retain stubborn deposits in the flanks and thighs. Liposuction precisely targets those areas. If even 5–10% of GLP-1 patients seek lipo, volume could approach 400K–450K.
1
Liposuction is the #1 cosmetic surgical procedure in America.
350K procedures in 2024 — more than augmentation (306K), more than tummy tucks (171K), more than anything else.
2
It grew 73% from its 2012 trough.
202K to 350K — one of the fastest-growing major surgical procedures in the 20-year ASPS dataset.
3
It's the only major surgical procedure with meaningful male volume.
21K male procedures in 2024 (6% of total). Liposuction is one of the top 5 cosmetic procedures for men.
4
Florida overtook California as the lipo capital.
The South Atlantic region surged from 23% to 35% of all liposuction, while the Pacific dropped from 31% to 24%.
5
GLP-1 drugs make liposuction uniquely positioned for growth.
Weight-loss drugs reduce fat unevenly, creating ideal lipo candidates. Volume could approach 400K–450K within years.